Clinical characteristics and treatment outcomes of HER2 mutation and HER2 fusion in 22 patients with advanced breast cancer

BACKGROUND: The clinical characteristics and efficacy of human epidermal growth factor receptor‐2 (HER‐2)‐directed agents against HER2 mutations and HER2 fusions in breast cancer are obscure due to their low frequency. METHODS: We conducted a retrospective study in patients with advanced breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Yuxin, Meng, Yanchun, Du, Yiqun, Liu, Xiaojun, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693943/
https://www.ncbi.nlm.nih.gov/pubmed/37863840
http://dx.doi.org/10.1111/1759-7714.15130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693943/
https://www.ncbi.nlm.nih.gov/pubmed/37863840
http://dx.doi.org/10.1111/1759-7714.15130

Ejemplares similares